COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 870: Articles 8691-8700  | Next

Pharmacokinetics of favipiravir in adults with mild COVID-19 in Thailand
Manosuthi, W., Prasanchaimontri, I.-o., Niyomnaitham, S., Sirijatuphat, R., Charoenpong, L., Copeland, K., Cressey, T. R., Mokmued, P., Chokephaibulkit, K.
10.1101/2022.03.09.22271220 — Posted: 2022-03-12
Alveolar regeneration following viral infection is independent of tuft cells
Que, J., Huang, H., Jiang, M., Zhang, Y., Biermann, J., Melms, J. C., Danielsson, J., Fang, Y., Yang, Y., Qiang, L., Liu, J., Zhou, Y., Wang, M., Hu, Z., Wang, T., Saqi, A., Sun, J., Matsumoto, I., Cardoso, W. V., Emala, C., Zhu, J., Izar, B., Mou, H.
10.1101/2022.03.11.483948 — Posted: 2022-03-12
Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development
Imprachim, N., Yosaatmadja, Y., Newman, J.
10.1101/2022.03.11.483836 — Posted: 2022-03-12
Innate immune response and distinct metabolomic signatures together drive and shape the SARS-CoV-2-specific T cell response during COVID-19
Binayke, A., Zaheer, A., Dandotiya, J., Gupta, S. K., Mani, S., Tripathy, M. R., Madan, U., Shrivastava, T., Kumar, Y., Pandey, A. K., Rathore, D. K., Awasthi, A.
10.1101/2022.03.11.483930 — Posted: 2022-03-12
Immunogenicity and safety of a recombinant adenovirus type-5 COVID 19 vaccine in adults: data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
Dzutseva, V., Lioznov, D., Amosova, I., Sheetikov, S. A., Zornikova, K. V., Serdyuk, Y., Efimov, G. A., Tsyferov, M., Khmelevskii, M., Afansiev, A., Khomyakova, N., Zubkov, D., Tikhonov, A., Zhu, T., Barreto, L.
10.1101/2022.03.01.22271507 — Posted: 2022-03-11
Increased receptor affinity and reduced recognition by specific antibodies contribute to immune escape of SARS-CoV-2 variant Omicron
Vogt, A.-C. S., Augusto, G., Martina, B., Chang, X., Nasrallah, G., Speiser, D. E., Vogel, M., Bachmann, M. F., Mohsen, M.
10.1101/2022.03.11.483934 — Posted: 2022-03-11
Trajectories of gene expression, seasonal influenza, and within-host seasonal immunity: transfer value to covid-19
Lund, E., Holden, M., Busund, L.-T. R., Snapkov, I., Shvetsov, N., Holden, L.
10.1101/2022.03.01.22271679 — Posted: 2022-03-11
Performance evaluation of a non-invasive one-step multiplex RT-qPCR assay for detection of SARS-CoV-2 direct from human saliva
Jenkins, H. H., Tellechea Lopez, A. A., Tarantini, F. S., Tomlin, H., Scales, D., Lee, I.-N., Wu, S., Hyde, R., Lis-Slimak, K., Byaruhanga, T., Thompson, J. L., Pijuan-Galito, S., Doolan, L., Kaneko, K., Gwynne, P., Reffin, C., Park, E., Dey, J., Hill, J., Arendt-Tranholm, A., Stroud, A., Petrie, M., Denning, C., Benest, A. V., Seedhouse, C.
10.1101/2022.03.09.22272125 — Posted: 2022-03-10
Symptoms of depression and anxiety among Vietnamese immigrants in Japan during the COVID-19 pandemic
Yamashita, T., Nguyen Quy, P., Nogami, E., Seto-Suh, E., Yamada, C., Iwamoto, S., Shimazawa, K., Kato, K.
10.1101/2022.03.09.22271973 — Posted: 2022-03-10
Impacts of COVID-19 on glycemia and risk of diabetic ketoacidosis
Sharma, A., Misra-Herbert, A. D., Mariam, A., Milinovich, A., Kattan, M. W., Pantalone, K. M., Rotroff, D. M.
10.1101/2022.03.08.22272041 — Posted: 2022-03-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).